Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Conditions: Gallbladder Cancer; Initially Unresectable; the First Line Treatment Intervention: Drug: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab Sponsor: Lu Wang, MD, PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2023 Category: Research Source Type: clinical trials
Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer
Condition: Gallbladder Cancer Intervention: Diagnostic Test: CT scan Sponsors: Postgraduate Institute of Medical Education and Research, Chandigarh; Radiological Society of North America Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials